search
Back to results

Meatal Swab Yourself With Testing for Infections Collectively (MYSTIC)

Primary Purpose

Chlamydia, Gonorrhea

Status
Not yet recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
All participants
Sponsored by
The Leeds Teaching Hospitals NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Chlamydia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria: 18 years and over. Willing to perform self-taken swabs in addition to any clinician required swabs. Able to provide informed consent Exclusion Criteria: - Antibiotics taken in the past 14 days (excluding metronidazole). Previous participation in this trial

Sites / Locations

  • Leeds Teaching Hospitals NHS Trust

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

All participants

Arm Description

All participants will receive: Clinician or self-taken, pharyngeal and rectal swabs with FCU analysed individually Self-taken pharyngeal, meatal, and rectal swabs analysed as a pooled specimen Self-taken pharyngeal and rectal swabs with 1.5ml FCU analysed as a pooled specimen The FCU will be done after any meatal swabs. Patients will be instructed to only pass the first 5ml into the tube, and the tube will be pre-marked with a black line. Full pictoral instructions and verbal support will be given to enable them to complete the pooling process of the swabs and urine.

Outcomes

Primary Outcome Measures

Sensitivity and specificity for gonorrhoea, chlamydia and LGV diagnosis using NAATS
To improve the accuracy of chlamydia diagnoses in MSM and trans-women by comparing two new pooling methods with the 3-samples tested separately, and to assess the diagnostic accuracy of pooled specimens for lymphogranuloma venereum detection (LGV) - a type of chlamydia infection

Secondary Outcome Measures

Participant satisfaction with using meatal swabs compared with first catch urine for the diagnosis of gonorrhoea, chlamydia, and LGV as measured by a Likert scale
To assess participant satisfaction with using self-taken meatal swabs compared with FCU, participants will complete a questionnaire following their self sampling. Satisfaction will be assessed using a 5 point Likert scale, checking for ease of use, discomfort when sampling, and belief in validity of results.
Participant satisfaction with taking and pooling combined site samples, compared with individually analysed samples for the diagnosis of gonorrhoea, chlamydia, and LGV as measured by a Likert scale
To assess participant satisfaction with taking and pooling combined site samples compared with individually analysed samples, participants will complete a questionnaire following their self sampling. Satisfaction will be assessed using a 5 point Likert scale, checking for ease of process, clarity of instructions, and belief in validity of results.

Full Information

First Posted
April 28, 2023
Last Updated
July 14, 2023
Sponsor
The Leeds Teaching Hospitals NHS Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT05870098
Brief Title
Meatal Swab Yourself With Testing for Infections Collectively
Acronym
MYSTIC
Official Title
Meatal Swab Yourself With Testing for Infections Collectively (MYSTIC)
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 29, 2023 (Anticipated)
Primary Completion Date
May 29, 2024 (Anticipated)
Study Completion Date
August 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Leeds Teaching Hospitals NHS Trust

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this study is to improve the accuracy of chlamydia multi-site testing in men who have sex with men (MSM) and trans-women, whilst saving diagnostic costs, by comparing two new pooling methods with the 3-samples tested separately to assess the diagnostic accuracy of pooled specimens for lymphogranuloma venereum detection (LGV) - a type of chlamydia infection Chlamydia and gonorrhoea testing for MSM and trans-women usually involves 3 samples from the throat, bum and wee-pipe. The tests can be combined into a single sample pot (pooled sample) which reduces costs, but in a previous study this reduced the accuracy for finding chlamydia. The main question for this study is: Can the accuracy of chlamydia testing in a pooled sample be improved by reducing the amount of urine added to minimise dilution, or by using a meatal sample instead of a urine sample? Participants will be asked to complete two sets of their own throat and bum samples, and then combine these into two pooled samples with 1)a meatal swab and 2)a smaller amount of first catch urine. The order of these samples will be randomised. These samples will be compared against separate samples taken at the same visit, to see how accurate the pooled samples are at diagnosing chlamydia and gonorrhoea with the different sampling techniques.
Detailed Description
Testing for chlamydia and gonorrhoea in men who have sex with men (MSM) and trans-women is recommended every three months for those taking HIV Pre-Exposure Prophylaxis (PrEP). Testing requires throat and bottom samples, and samples from the urethra (wee-pipe), usually a urine sample. However, many sexual health services struggle to afford the costs of these 3-samples, four-times per year, which may restrict numbers given PrEP. The investigators' previous research has shown that the 3-samples (throat, bottom, urine) can be combined into one pooled specimen to accurately find gonorrhoea and reduce laboratory costs. However, the chlamydia results of pooled samples were not as good, finding only 92 out of 100 infections compared with 99 out of 100 with 3 separate samples. The investigators' past research showed no difference in diagnostic accuracy between clinician and self-taken rectum and pharynx swabs for NG and CT detection. People prefer to take their own swabs and self-taken swabs were more cost effective than clinician taken. Self-taken swabs are now used routinely in clinical practice and are available as on-line ordered commercial kits. This study aims to improve the accuracy of chlamydia results by comparing two new pooling methods with the 3-samples tested separately. MSM, and trans-women, aged 18 years or over, attending a large UK city sexual health service for chlamydia and gonorrhoea testing will be invited to take part in the study. The pooling methods will be: 1) pooling with a smaller amount of urine to reduce the dilution of the other samples; and 2) pooling with a swab sample from the outside of the tip of the penis (meatal swab) instead of urine. Meatal swabs are taken by the person themselves. The swab does not go inside the penis so is easy to do and not painful. Studies suggest meatal swabs may be better at finding chlamydia than urine samples. To ensure an accurate comparison, the order of taking the two pooling method samples, and the 3-samples tested separately, will be randomised. The study will recruit 1250 participants. This is a large enough number to show if either of the pooling methods can detect more chlamydia than 92 out of 100 infections. If a pooling technique was developed for MSM and trans-women that did not reduce diagnostic sensitivity, this would likely be implemented. A sensitive, low-cost, method of triple-site STI testing, available on-line, or using minimal in-house staff, would enable increased testing. The investigators believe this study will identify such a method by using meatal swabs or a reduced urine volume. The reduced diagnostic costs of almost two-thirds would enable sexual health clinics to provide PrEP to more people, and/or utilise the money saved elsewhere in their service.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chlamydia, Gonorrhea

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Diagnostic accuracy study Single group receiving standard care plus two new comparators
Masking
None (Open Label)
Masking Description
Laboratory staff will be masked and will not be able to link pooled samples (sent under a unique study number) to comparator standard care separate samples (sent under a unique patient identifier).
Allocation
N/A
Enrollment
1250 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
All participants
Arm Type
Other
Arm Description
All participants will receive: Clinician or self-taken, pharyngeal and rectal swabs with FCU analysed individually Self-taken pharyngeal, meatal, and rectal swabs analysed as a pooled specimen Self-taken pharyngeal and rectal swabs with 1.5ml FCU analysed as a pooled specimen The FCU will be done after any meatal swabs. Patients will be instructed to only pass the first 5ml into the tube, and the tube will be pre-marked with a black line. Full pictoral instructions and verbal support will be given to enable them to complete the pooling process of the swabs and urine.
Intervention Type
Diagnostic Test
Intervention Name(s)
All participants
Intervention Description
Clinician or self-taken, pharyngeal and rectal swabs with FCU analysed individually Self-taken pharyngeal, meatal, and rectal swabs analysed as a pooled specimen Self-taken pharyngeal and rectal swabs with 1.5ml FCU analysed as a pooled specimen The FCU will be done after any meatal swabs. Patients will be instructed to only pass the first 5ml into the tube, and the tube will be pre-marked with a black line. Full pictoral instructions and verbal support will be given to enable them to complete the pooling process of the swabs and urine.
Primary Outcome Measure Information:
Title
Sensitivity and specificity for gonorrhoea, chlamydia and LGV diagnosis using NAATS
Description
To improve the accuracy of chlamydia diagnoses in MSM and trans-women by comparing two new pooling methods with the 3-samples tested separately, and to assess the diagnostic accuracy of pooled specimens for lymphogranuloma venereum detection (LGV) - a type of chlamydia infection
Time Frame
14 months
Secondary Outcome Measure Information:
Title
Participant satisfaction with using meatal swabs compared with first catch urine for the diagnosis of gonorrhoea, chlamydia, and LGV as measured by a Likert scale
Description
To assess participant satisfaction with using self-taken meatal swabs compared with FCU, participants will complete a questionnaire following their self sampling. Satisfaction will be assessed using a 5 point Likert scale, checking for ease of use, discomfort when sampling, and belief in validity of results.
Time Frame
14 months
Title
Participant satisfaction with taking and pooling combined site samples, compared with individually analysed samples for the diagnosis of gonorrhoea, chlamydia, and LGV as measured by a Likert scale
Description
To assess participant satisfaction with taking and pooling combined site samples compared with individually analysed samples, participants will complete a questionnaire following their self sampling. Satisfaction will be assessed using a 5 point Likert scale, checking for ease of process, clarity of instructions, and belief in validity of results.
Time Frame
14 months

10. Eligibility

Sex
Male
Gender Based
Yes
Gender Eligibility Description
Males who have sex with males, and trans-females with a penis
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 18 years and over. Willing to perform self-taken swabs in addition to any clinician required swabs. Able to provide informed consent Exclusion Criteria: - Antibiotics taken in the past 14 days (excluding metronidazole). Previous participation in this trial
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Janet Wilson, MB ChB
Phone
00 44 113 3920323
Email
janet-d.wilson@nhs.net
First Name & Middle Initial & Last Name or Official Title & Degree
Harriet Wallace, MB ChB
Phone
00 44 113 3920323
Email
harriet.wallace@nhs.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Janet Wilson, MB ChB
Organizational Affiliation
Leeds Teaching Hospitals NHS Trust
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Harriet Wallace, MB ChB
Organizational Affiliation
Leeds Teaching Hospitals NHS Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
Leeds Teaching Hospitals NHS Trust
City
Leeds
State/Province
West Yorkshire
ZIP/Postal Code
LS1 3EX
Country
United Kingdom
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Janet Wilson, MB ChB
Phone
00 44 113 3920323
Email
janet-d.wilson@nhs.net
First Name & Middle Initial & Last Name & Degree
Harriet Wallace, MB ChB
Phone
00 44 113 3920323
Email
harriet.wallace@nhs.net

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Meatal Swab Yourself With Testing for Infections Collectively

We'll reach out to this number within 24 hrs